These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23627311)

  • 41. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
    Vance KM; Hansen KB; Traynelis SF
    J Physiol; 2012 Aug; 590(16):3857-75. PubMed ID: 22641781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
    Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
    J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remifentanil directly activates human N-methyl-D-aspartate receptors expressed in Xenopus laevis oocytes.
    Hahnenkamp K; Nollet J; Van Aken HK; Buerkle H; Halene T; Schauerte S; Hahnenkamp A; Hollmann MW; Strümper D; Durieux ME; Hoenemann CW
    Anesthesiology; 2004 Jun; 100(6):1531-7. PubMed ID: 15166575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of thiophenic analogues of benzothiadiazine dioxides as new powerful potentiators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors.
    Francotte P; Goffin E; Fraikin P; Graindorge E; Lestage P; Danober L; Challal S; Rogez N; Nosjean O; Caignard DH; Pirotte B; de Tullio P
    J Med Chem; 2013 Oct; 56(20):7838-50. PubMed ID: 24090223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specificity of putative partial agonist, 1-aminocyclopropanecarboxylic acid, for rat N-methyl-D-aspartate receptor subunits.
    Sheinin A; Nahum-Levy R; Shavit S; Benveniste M
    Neurosci Lett; 2002 Jan; 317(2):77-80. PubMed ID: 11755244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytes.
    Puddifoot CA; Chen PE; Schoepfer R; Wyllie DJ
    Br J Pharmacol; 2009 Feb; 156(3):509-18. PubMed ID: 19154422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
    Wrighton DC; Baker EJ; Chen PE; Wyllie DJ
    J Physiol; 2008 Jan; 586(1):211-25. PubMed ID: 17962329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.
    Hansen KB; Traynelis SF
    J Neurosci; 2011 Mar; 31(10):3650-61. PubMed ID: 21389220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.
    de Carvalho LP; Bochet P; Rossier J
    Neurochem Int; 1996 Apr; 28(4):445-52. PubMed ID: 8740453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
    D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
    Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
    Mosley CA; Acker TM; Hansen KB; Mullasseril P; Andersen KT; Le P; Vellano KM; Bräuner-Osborne H; Liotta DC; Traynelis SF
    J Med Chem; 2010 Aug; 53(15):5476-90. PubMed ID: 20684595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors.
    Wang JX; Irvine MW; Burnell ES; Sapkota K; Thatcher RJ; Li M; Simorowski N; Volianskis A; Collingridge GL; Monaghan DT; Jane DE; Furukawa H
    Nat Commun; 2020 Jan; 11(1):423. PubMed ID: 31969570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists.
    Hansen KB; Mullasseril P; Dawit S; Kurtkaya NL; Yuan H; Vance KM; Orr AG; Kvist T; Ogden KK; Le P; Vellano KM; Lewis I; Kurtkaya S; Du Y; Qui M; Murphy TJ; Snyder JP; Bräuner-Osborne H; Traynelis SF
    J Pharmacol Exp Ther; 2010 Jun; 333(3):650-62. PubMed ID: 20197375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
    Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
    J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.